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Abstract
Background: Elevated blood pressure (BP), which is a major risk factor for cardiovascular disease, is highly prevalent
worldwide. Recently, interest has grown in the role of dietary protein in human BP. We performed a systematic review of all
published scientific literature on dietary protein, including protein from various sources, in relation to human BP.
Methodology/Principal Findings: We performed a MEDLINE search and a manual search to identify English language
studies on the association between protein and blood pressure, published before June 2010. A total of 46 papers met the
inclusion criteria. Most observational studies showed no association or an inverse association between total dietary protein
and BP or incident hypertension. Results of biomarker studies and randomized controlled trials indicated a beneficial effect
of protein on BP. This beneficial effect may be mainly driven by plant protein, according to results in observational studies.
Data on protein from specific sources (e.g. from fish, dairy, grain, soy, and nut) were scarce. There was some evidence that
BP in people with elevated BP and/or older age could be more sensitive to dietary protein.
Conclusions/Significance: In conclusion, evidence suggests a small beneficial effect of protein on BP, especially for plant
protein. A blood pressure lowering effect of protein may have important public health implications. However, this warrants
further investigation in randomized controlled trials. Furthermore, more data are needed on protein from specific sources in
relation to BP, and on the protein-BP relation in population subgroups.
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Introduction
Elevated blood pressure (BP) is an independent risk factor for
cardiovascular diseases (CVD) and renal impairment.[1] There is
no evidence for a threshold effect: from systolic BP levels as low as
115 mmHg onward, risk of CVD doubles for each increment of
20 mmHg.[1] It has been estimated that, at population level, a
reduction in systolic BP of only 2 mmHg would result in a 6%
reduction in fatal stroke, and a 4% reduction fatal coronary heart
disease (CHD).[2]
Well-known dietary and lifestyle interventions to prevent hyperten-
sion include moderate physical activity, maintenance of normal body
weight, low alcohol and salt intake, and a diet rich in fruits, vegetables,
and low-fat dairy products.[2,3] More recently, interest has grown into
dietary patterns and macronutrient intakes, including protein.[4,5]
Whether protein content of the diet or type of protein is important for
human BP is, however, unclear. We systematically reviewed all
scientific literature, published before June 2010, on dietary protein in
relation to human BP, with a focus on specific types of protein and
possible interactions with age, gender, BP level, and overweight.
Methods
Ethical approval was not required for this review because only
published data were included.
Search strategy
A systematic search was performed in MEDLINE (www.ucbi.
ulm.nih.gov) to identify studies on the association between dietary
protein and BP, published before June 2010. Search terms on
dietary protein and BP or hypertension were used to search for
words in title or abstract and Medical Subject Headings. The
search was limited to studies in human adults and English-
language literature. In addition, we performed a manual search
using reference lists of original articles and previous reviews [6–9].
For all studies, we retrieved the original publication.
We selected any observational study or trial that examined the
relationship between dietary protein and BP in humans. All titles,
abstracts, and full papers of potentially relevant studies were
assessed for eligibility based on predefined inclusion and exclusion
criteria. Papers were excluded: 1) if data on exposure (dietary
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protein) or outcome (BP, hypertension) was not reported, 2) if no
data were reported on the relationship between exposure and
outcome, 3) if the exclusive effect of protein could not be
calculated (e.g. BP studies that focused on dietary patterns, or soy
combined with isoflavones). Furthermore, review papers were
excluded, as were drug trials and studies conducted in patient
groups or pregnant women.
Data collection and data synthesis
From each included paper we extracted data on protein intake,
source of protein, and BP values or estimated risk of hypertension
according to a predefined standard form. In addition, we extracted
data on design, place of study, number of participants, population
characteristics (including initial BP, sex, and age), dietary
assessment method (food frequency questionnaire (FFQ), 24-hour
recall, food diary, biomarker), adjustment for confounders, and
measures of variation.
To allow better comparison of results from observational studies
we expressed associations in these studies by standard units of
protein intake that correspond to approximately 1 SD of protein
intake in the Dutch population, i.e. 25 g/d (3.5 en%) for total
protein, 11 g/d (1.4 en%) for plant protein, and 23 g/d (2.9 en%)
for animal protein.[10,11]
Results
The systematic search in MEDLINE resulted in 2,681 titles to
be screened. Inclusion criteria were fulfilled by 40 papers, and the
hand search yielded another 6 papers (Figure 1). In total, 15
observational studies, 13 biomarker studies and 20 trials were
selected.
Total dietary protein and BP: observational data
Twelve observational studies focused on habitual total protein
intake and BP or risk of hypertension (table 1). Most of these
studies had a cross-sectional design and showed predominantly
weak inverse associations.[12–20] However, although hypothesis-
generating, a major drawback of a cross-sectional design is that
protein intake and BP are assessed at the same moment in time,
which makes it difficult to address the temporality of the
association. Subjects with elevated BP, or otherwise at increased
cardiovascular risk, may have changed their food intake (including
protein intake) upon medical advice. Causality can, therefore, be
better established in prospective studies.
So far, only three studies prospectively examined the association
of total dietary protein with change in BP or incident
hypertension. Total protein intake was not clearly associated with
change in systolic BP after 8 years of follow up in 1714 US men
(+0.16 mmHg per y per 3.5 en% systolic, p = 0.04) [21], and after
7 years of follow up in 4146 young US adults (20.20 mmHg per
year per 3.5 en% systolic, p.0.05) [22]. It should be noted that in
these two studies respondents using antihypertensive medication
were not excluded from the analyses, which may have affected the
associations. In 5880 university graduates of the prospective SUN
cohort, not using antihypertensive medication, a non-significant
20% lower 2-year hypertension risk was found (p = 0.26).[23] In
Figure 1. Flow chart of systematic literature search. *Numbers overlap because several studies investigated different types of protein.
{Numbers overlap because two studies investigated protein intake using questionnaires as well as biomarkers.
doi:10.1371/journal.pone.0012102.g001
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this study the population was quite young (mean age ,36 y), and
BP may not have been as sensitive to influence from protein intake
as in an older population.
Concluding, most cross-sectional studies on total protein intake
and BP or incident hypertension showed a weak inverse
association, whereas no clear conclusion could be drawn from
prospective studies. A small beneficial effect on BP may exist, but
well conducted prospective studies and randomized controlled
trials may provide better estimates of a protein effect on BP.
Biomarkers of total dietary protein and BP: observational
data
Daily urinary nitrogen excretion, about 85% excreted in the
form of urea, correlates with dietary protein as calculated from
weighed food records (r = 0.4–0.8) and reflects ,80% of total
protein intake.[24] As shown in table 2, in five cross-sectional
studies urinary total nitrogen [25] or urinary urea nitrogen
[11,25–28] was used to estimate the association between total
protein intake and BP.
In the large INTERSALT-study, including 10,020 adults from
32 countries, an inverse association of 20.5 mmHg systolic
(p,0.01) per g of total 24-h urinary nitrogen was observed.[25]
Also in 4,680 respondents from the INTERMAP study, 24 h urea
nitrogen was inversely related to systolic BP (20.9 mmHg per
5.34 g), although this was not statistically significant.[11] In the
remaining studies, summarized in table 2, single spot or overnight
urines were used to estimate protein intake.[26–28] Although
these estimates are less reliable than estimates from 24-h urine, the
results were in line with those of the studies mentioned above.
Concluding, in studies among participants that are in nitrogen
balance, good agreement has been found between one or two 24-h
urine collections and diet-history estimates of protein intake.[24]
Findings from biomarker studies, therefore, suggest that protein
intake may have a beneficial effect on BP.
Total dietary protein and BP: trial data
In 16 trials the BP effect of a high protein diet was assessed
(table 3). Most trials were only small (number of participants per
intervention group: n = 7 to n= 30), and the conflicting results may
be due to chance findings.[29–39] In one of the larger trials, a
parallel trial in which 121 type 2 diabetes patients received
counseling on normal or reduced protein intake, an increase in BP
was found (+5.4 mmHg systolic, p = 0.07).[40] However, the low
range of intake may have influenced the results. Another large
parallel trial among 311 obese women, in which different weight
loss diets were compared, showed a decrease in systolic BP of
25.7 mmHg systolic (p value not given).[41] However, contrast in
protein intake was low (2.3 en%), and BP decrease may be a result
of exchange in carbohydrates and fat instead of increase in protein
intake. Other large studies showed a decrease in BP on a high
protein diet, although no clear dose-response relation could be
distinguished.[5,42,43] In 100 obese participants with metabolic
syndrome, systolic BP changed 26 mmHg (p,0.05) with 6 en%
higher protein intake [42], and in 141 obese adults 6 en% higher
protein intake resulted in a BP change of 24.6 mmHg (p= 0.04)
[43].
In almost all trials the high protein diet was compared with a
high carbohydrate diet. The only study in which two different
control diets were included was the OmniHeart trial.[5] In this 6-
week, fully controlled cross-over feeding trial in 164 healthy US
adults partial substitution of carbohydrates (10 en%) with protein
significantly lowered systolic BP with 21.4 mmHg systolic
(p = 0.002). No difference in BP response was observed when the
protein-rich diet was compared with a diet high in mono-
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unsaturated fat (20.1 mmHg systolic, p = 0.90). Recently, a trial
was conducted in which only a high fat diet was included as
control diet.[38] In this trial, however, the number of participants
was very low (n= 17), and the systolic BP effect of 29 mmHg may
be a chance finding.
In conclusion, the results of trials suggest that increased intake
of protein may be beneficial to BP, although no clear dose –
response association could be distinguished. From the results of
the OmniHeart study, the only trial in which two different
isocaloric control diets (high in carbohydrates and high in fat)
were used, a conclusion can be drawn that both protein and
mono-unsaturated fat have blood pressure lowering properties.
However, it is also possible that a reduced intake of carbohy-
drates, rather than a higher intake of mono-unsaturated fat or
protein, is responsible for a reduced blood pressure. In a trial on
macronutrients and blood pressure it is important to keep energy
intake in both treatment groups constant, to rule out blood
pressure effects of energy and change in weight. Measurements of
blood pressure effects after high intake of one of the macronu-
trients, therefore, will always be relative to the intake of the other
two macronutrients, and the answer to the question whether total
protein intake itself influences blood pressure may never be given,
unless specific mechanisms are found through which protein
intake may affect blood pressure.
Dietary plant protein and BP: observational data
The association between dietary plant protein and BP or
hypertension was examined in 8 observational studies (Table 4).
Most cross-sectional studies showed an inverse association
[11,14,15,19,20,44], and this was confirmed in prospective studies
[20,21,23]. In a prospective study among 1714 men a systolic BP
difference of 20.34 mmHg per year per 1.4 en% (p,0.01) was
found after a follow-up of 8 y.[21] It should be noted, however,
that estimates were not adjusted for important potential con-
founders like sodium and potassium. In two other studies, in which
estimates were adjusted for these confounders, a 21% reduction in
hypertension risk per en% of plant protein intake (p= 0.08) was
found after 18 months of follow-up in 810 untreated pre- or mild
hypertensives of the PREMIER study [20], and a 50% lower 2
year hypertension risk for the highest quintile of plant protein
intake versus the lowest quintile (p = 0.06) was found in 5880
university graduates of the SUN cohort [23].
Table 2. Observational studies of biomarkers of total protein intake and blood pressure.
Author,
year respondents
Initial BP
(mmHg)
Habitual
protein
intake
Dietary
assessment BP outcome (SBP/DBP) P-value tatistical adjustment
cross-sectional studies
Kihara,
1984[28]
1120 traditional
Japanese aged
over 30 y
M: 132/79 … Urea nitrogen/
Cr in single-spot
urine (mol:mol)
M: +0.13/+0.02 mmHg
per unit (partial regression
coefficients)
,0.05/NS …
F: 129/76 … Urea nitrogen/
Cr in single-spot
urine (mol:mol)
F: 20.04/20.01 mmHg
per unit (partial regression
coefficients)
NS/NS …
Iseki,
2003[27]
1299 Japanese
adults, mean
age ,49 y1
,121/74 ,1.1
g/kg/day
Urea nitrogen
in single spot
urine
23.0/22.4 mmHg per
g/kg/day
…/… Unadjusted
Cirillo,
2002[26]
3705 Italian
adults aged
25–74 y1
127/76 … Urea nitrogen
in overnight
urine
25.2/… mmHg per
log(urea)
in mmol/h
,0.01/… Age, sex, BMI, exercise, alcohol,
smoking, antihypertensive drugs,
urinary Na, K, Ca, creatinine clearance
Elliott,
2006[11]
(INTER-MAP)
4680 respondents
from China,
Japan, UK and
USA aged
40–59 y1
119/74 China: 12
en%; Other
countries:
15–16 en%
Urea nitrogen
in 24 h urine
M: 20.77/20.40 mmHg
per 5.34 g/24 h (2 SD)
NS/NS …
F: 21.11/20.41 mmHg
per 5.34 g/24 h
NS/NS
Stamler,
1996a[25]
(INTER-SALT)
10020 adults from
32 countries
worldwide aged
20–59 y1
119/73 … Total nitrogen
in 24-h urine
20.50 mmHg per g/20.41
mmHg per g
,0.01/
,0.01
Age, sex, BMI, alcohol and 24 h
urinary Na, K, Ca, Mg; corrected
for regression dilution bias
Older respondents
(40–59 y): 20.92/20.48
mmHg per g
,0.01/
,0.05
Age, sex, BMI, alcohol and 24 h
urinary Na, K, Ca, Mg; corrected
for regression dilution bias
Younger respondents
(20–39 y): 20.20/20.38
mmHg per g
…/,0.05 Age, sex, BMI, alcohol and 24 h
urinary Na, K, Ca, Mg; corrected
for regression dilution bias
Stamler,
1996a
(INTER-SALT)
10020 adults from
2 countries
worldwide aged
20–59 y1
119/73 … Urea nitrogen
in 24-h urine
20.57/20.50 mmHg
per g
,0.05/
,0.01
Age, sex, BMI, alcohol and 24 h
urinary Na, K, Ca, Mg; corrected
for regression dilution bias
BP= blood pressure, SBP = systolic blood pressure, DBP = diastolic blood pressure, M=men, F =women, Na = sodium, K = potassium, Ca = calcium, BMI =body mass
index; PUFA =polyunsaturated fat, SFA = saturated fat, 3MH= 3-methylhistidine; Cr = creatinine; NS =not statistically significant (p.0.05); … = value not given.
1Users of anti-hypertensive medication were not excluded.
doi:10.1371/journal.pone.0012102.t002
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In conclusion, results from observational studies indicate an
inverse association between dietary plant protein and BP.
However, despite adjustment for many potential confounders in
multivariable models, residual confounding (e.g. by other macro-
nutrients, fiber or flavonoid intake) in observational studies cannot
fully be excluded.
Dietary animal protein and BP: observational data
In 7 observational studies the relationship between dietary
animal protein and BP was investigated (Table 5), with results
from cross-sectional studies being inconclusive [11,15,19,20,45].
In studies with a prospective design no association or only weak
associations were observed, with systolic BP differences of
20.06 mmHg per 2.9 en% (p= 0.84) after 6 months in 810
untreated pre- or mild hypertensives [20], and +0.16 mmHg per
2.9 en% per year (p,0.01) in 1714 men.[21] Furthermore, no
difference in hypertension risk with high intake of animal protein
was observed in 5880 university graduates of the SUN cohort.[23]
In conclusion, observational studies provide no evidence for an
association of animal protein with BP. However, also for these
studies, despite inclusion of many potential confounders in their
multivariate model, residual confounding (e.g. by intake of other
macronutrients or salt) cannot be excluded.
Biomarkers of dietary plant protein or animal protein and
BP: observational data
We did not find any studies that used a biomarker specifically
for plant protein intake. With regard to animal protein intake,
urinary excretion of 3-methylhistidine (3-MH) has been suggested
as marker of meat consumption because it is synthesized in the
muscle of mammals and released and excreted in urine after intake
of muscle protein.[46] Six cross-sectional studies included in this
review used urinary 3-MH excretion to estimate animal protein
intake in predominantly Asian populations (Table 6). Overlap
between studies may exist, since all populations formed part of the
study population of the World Health Organization Cardiovas-
cular Disease and Alimentary Comparison (CARDIAC) study,
which is an international population-based cross-sectional study in
more than 20 countries, among which are China and Japan. All
studies showed inverse associations with BP. However, because
studies were conducted mainly in Asian populations, results may
not be generalizable to other populations. Furthermore, urinary 3-
MH may partly reflect muscle catabolism in the human body itself,
i.e. during starvation, cachexia, or heavy physical activity.[52]
This phenomenon was not taken into account in the various
studies, and overestimation of associations between animal protein
and BP could have occurred. The findings of these biomarker
studies, therefore, should not be overemphasized. A challenge for
future protein research will be to find reliable biomarkers for plant
and animal protein and intake of protein from specific dietary
sources.
Dietary plant protein or animal protein and BP: trial data
The BP response after protein intake from plant and animal
sources was investigated in only 2 randomized controlled trials
(table 7). A systolic BP effect of +1 mmHg systolic (p = 0.90) was
seen in 23 type 2 diabetics after a diet containing protein only from
plant sources (from soy, vegetables, and legumes) compared to a
diet in which 60% of the plant protein was replaced by animal
protein (from beef, poultry, fish, and milk).[53] However, the
number of 23 participants is low, and this BP effect was not
significant. Furthermore, these participants suffered from albu-
minuria, which may have influenced the results on BP. In 49
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healthy students a soy protein isolate resulted in a non significant
systolic BP response of +0.6 mmHg (p-value unknown) compared
to a casein protein isolate.[54] However, because in this trial only
soy protein and casein protein were investigated, we cannot
extrapolate these findings to plant protein and animal protein from
a mix of sources.
In summary, only 2 small trials evaluated the BP effect of plant
protein versus animal protein. More evidence on the BP effect of
plant and animal protein is needed from large randomized
controlled BP trials.
Dietary protein from specific sources and BP
Only few observational studies addressed the relation of protein
from specific sources (e.g. fish, meat) to BP. In five studies the
association with BP was examined for urinary taurine [49,50,55]
or serum taurine [45,56] which the authors regarded as a
biomarker of seafood protein intake (data not in table). Three of
these studies were conducted among Asian populations (n = 705 to
n= 1,681) [45,49,50], whereas the others were conducted in Brazil
(n = 57) and USA (n= 168).[55,56] In all these studies inverse
associations with BP were observed, but no information about the
strength of the associations was given.
The BP effect of meat protein was only investigated in two trials
(data not in table).[57,58] In a parallel trial among 64 hospital staff
members, a diet with 40% of protein from meat sources (from
beef, chicken, lamb, sausage, pork, and prawns) resulted in a non-
significant BP effect of 21.8 mmHg systolic and 21.2 mmHg
diastolic (p-value not given) compared with a diet in which the
meat protein was replaced by plant protein (from cereals,
vegetables, legumes, and nuts).[57] In a small cross-over trial
among 35 men no difference in BP effect was seen (no p-value
given) between a diet including 50% of protein from meat (from
pork, beef, and chicken) compared with a diet in which the meat
protein was replaced by non-meat protein (from vegetables, eggs,
and dairy).[58]
Because isoflavones may influence BP [59], several studies on
soy could not be taken into account because observational data
were not adjusted for isoflavone intake [60–64], or because, in
trials, soy protein contained isoflavones [65–69]. To the best of our
knowledge, there are at present no other studies on specific protein
sources and BP. Epidemiological studies and randomized
controlled trials in this field are, therefore, warranted.
Dietary protein and BP in subgroups of the population
In several studies specific subgroup analyses were conducted to
identify subgroups whose BP is more sensitive for protein intake.
We explored, furthermore, whether differences in protein-BP
associations could be identified in the results of studies among
specific populations.
In the OmniHeart trial the effect of total dietary protein was
more pronounced in hypertensives than in prehypertensives
(23.5 mmHg versus 20.9 mmHg for systolic BP).[5] This
difference of protein effect in subgroups of BP could not be
recognized in observational studies. In trials, however, populations
with, on average, elevated BP were more sensitive to the BP
lowering effect of protein than populations with, on average,
normal BP (Out of 9 trials in populations with elevated BP
[5,29,30,35,37,38,40,42,43] 7 trials showed a decrease in BP with
high protein intake [5,30,35,37,38,42,43], whereas out of 7 trials
in populations with normal BP [31–34,36,39,41] only 2 trials
[34,41] showed a decrease).
With regard to age, in the INTERSALT study a stronger
inverse association of urinary nitrogen with BP was observed in
respondents aged 40–59 y than in respondents aged 20–39 y
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(systolic BP: 20.9 mmHg/g versus 20.2 g/d).[25] Furthermore,
inverse associations were found more often in studies conducted in
participants aged over 50 (out of 5 studies [5,29,30,35,40], in 3
studies an inverse association or a BP lowering effect was found
[5,30,35]) than in studies conducted in younger participants (out of
9 studies [16,22,23,31–34,39,41], in 4 studies an inverse
association was found [16,23,34,41]). However, the number of
studies that were conducted among these specific populations was
small, and solid conclusions cannot be drawn.
In a study on urinary 3-MH and BP, the inverse association was
more pronounced in respondents with a BMI higher than 26 kg/
m2 than in respondents with a normal BMI (D systolic
BP=26.8 mmHg versus 22.39 mmHg per 88 mmol urinary 3-
MH/d).[47] Among the other studies, however, only one study
was explicitly conducted among normal weight respondents[14],
so no conclusion can be drawn on difference in sensitivity related
to weight, although studies in overweight/obese participants often
showed inverse associations (Out of 11 studies [5,18,20,29,32,34–
37,41,42], 7 studies showed an inverse association or a decrease in
BP with high protein intake [5,29,34,35,37,41,42]).
Finally, in two studies subgroup-analyses were conducted for men
and women, but no effect modification was shown.[19,28] Also in
studies that were specifically conducted in men [12,13,17,21,25,33]
or women [36,37,41], no difference in sensitivity was seen.
In conclusion, the possible beneficial effect of protein intake on
BP seems stronger in people with higher initial BP and, possibly, in
older people. Additional predefined subgroup analyses in future
epidemiologic studies and trials in which subgroups are compared,
may provide better insight into the role of dietary protein in BP.
Discussion
A reduction in systolic BP of only 2 mmHg may already result
in a 6% reduction in fatal stroke, and a 4% reduction fatal
coronary heart disease (CHD).[2] Knowledge on the effect of
dietary protein, therefore, may have an important public health
impact. A substantial body of evidence suggests a, possibly weak,
beneficial effect of total dietary protein on BP, which may be most
apparent in populations with elevated BP and possibly older
populations. We cannot exclude, however, that this effect is due to
a lower carbohydrate intake. In observational studies more often
an inverse association was found for plant protein than for animal
protein. The beneficial effect of protein, therefore, may be mainly
due to protein from plant sources. Data on protein from specific
sources are too scarce to draw any conclusions.
The aim of the current systematic review was to give a
comprehensive overview of the evidence on dietary protein and
human BP, published until June 2010. Papers were independently
screened by 2 reviewers, and data of 46 studies were extracted using a
predefined procedure. Several other reviews on protein and BP have
already been conducted in the past.[6–9] However, the most
comprehensive review of these is already 14 years old.[9] Further-
more, the present review is the first to focus on possible BP effects of
different protein types and on sensitivity of population subgroups.
Several methodological issues of studies need to be addressed.
First, in observational studies, even after extensive adjustment for
potential confounders, residual confounding may exist from other
nutrients associated with protein intake, or from energy, which is
not only correlated to protein, but also to several other BP-
determinants like exercise, BMI, and dietary pattern. It is difficult
to say how much the remaining confounding from known or
unknown nutrients that are correlated to plant or animal protein,
have influenced the estimates in observational studies. Random-
ized controlled trials in which the effects of plant protein and
animal protein are compared, keeping other nutrients constant,
are needed. Second, a diet high in one type of protein (animal
protein or plant protein) does not necessarily mean that the other
protein type is replaced, as a diet may be high or low in both types
of protein. Most of the observational studies investigating types of
protein did not adjust their estimates for intakes of other protein
types. In randomized trials these factors are more standard-
ized.[70] Third, respondents in observational studies may be
misclassified according to their self-reported protein intake, which
may dilute the protein-BP association.[71] Fourth, for investiga-
tion of long-term effects of protein on BP, an observational study is
the most suitable type of study, because of the costs of a trial.
However, contrasts between high and low protein intake are often
larger in trials than in observational studies. Short term effects of
protein on BP can, therefore, be more easily detected in trials.
Finally, all observational studies were conducted in the general
population, whereas trials were more often conducted in selected
populations that are possibly more sensitive to BP interventions.
However, in several trials BP was the secondary outcome [29,31–
34,36,37,40–42,53]. If participants in these studies were not
blinded for the results of the BP-measurements, bias may have
been introduced, because awareness of BP may influence
participants’ lifestyle or other behavior.
The underlying mechanism for a potential beneficial effect of
protein on BP has not yet been clarified. Several hypotheses have
been put forward. First, dietary protein has been related to
synthesis of cellular ion channels, which may indirectly influence
the pathways in BP regulation.[25] High protein intake may
induce natriuresis, leading to lower BP.[26,65,72] Second,
experiments suggest that dietary protein or protein fractions could
improve insulin sensitivity and thereby BP.[73–75] Third, dietary
protein supplementation may result in a higher concentration of
the amino acids tyrosine and tryptophan in regions of the brain or
blood vessel wall, triggering a vasodilatory response.[76] The
amino acid arginine, which is a substrate for nitric oxide, may play
a role in vasodilatation, although it is unclear whether dietary
intake of arginine is relevant in this respect.[75,77] Finally, as has
already been stated in this review we cannot exclude that a lower
BP is related to a lower carbohydrate intake instead of a higher
protein intake.
In conclusion, evidence suggests a small beneficial effect of
protein on BP, especially for plant protein. More data on protein
from specific sources like dairy, grain or nuts and data in
population subgroups should be obtained from epidemiological
studies. Furthermore, there is a need for BP trials that focus on
plant and animal protein and protein from specific sources.
Preferably, these trials should be conducted in untreated
(pre)hypertensive people. Finally, studies aimed at potential BP
lowering mechanisms related to protein intake are warranted.
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